A71400
Ref A71400
A71400 is a Class III device made by Medtronic, Inc., registered in EUDAMED on 23 Jul 2026 (Basic UDI-DI 0763000B00008798V) with CE/MDR certificate G70 039709 1443 valid until 13 Aug 2028, approved under FDA PMA P840001 on 30 Nov 1984 and listed in FDA GUDID since 5 May 2024 (UDI-DI 00763000371463), active as of 25 Oct 2026. 9 FDA recalls are linked to it.
Active
Valid until
13 Aug 2028
FDA recalls
4 ongoingTrust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR EUDAMED | Number0763000B00008798V 00763000371463 | Date23 Jul 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00763000371463 | Date5 May 2024 | StatusListed |
| United States | FDA PMAAPPR GUDID | NumberP840001 | Date30 Nov 1984 | StatusActive |
Official records
- EUDAMED public site 0763000B00008798V
- AccessGUDID record 00763000371463
- FDA PMA database P840001
Across registries
- EUDAMED Basic UDI-DI 0763000B00008798V registered 23 Jul 2026 Active
- FDA PMA P840001 decided 30 Nov 1984 Active
- FDA GUDID UDI-DI 00763000371463 listed 5 May 2024 Listed
Certificates
- G70 039709 1443 Active
Technical documentation EU MDR
- Certifier
- TÜV SÜD Product Service GmbH 0123
- Issued
- 15 Jun 2026
- Expires
- 13 Aug 2028
- Reason
- Change approved
Recalls
-
- Ongoing Z-0372-2025
The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
-
- Ongoing Z-1691-2024
inability to reprogram one device
-
- Ongoing Z-0780-2024
Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability for the clinician to adjust stimulation parameters. In the event of this issue, the patient may receive inadequate or excessive therapy and experience non-optimal pain relief.
-
- Ongoing Z-2159-2021
Specific PINs of the Vectris SureScan MRI lead kits contain the incorrect lead electrode spacing information printed on the shelf box and the sterile pack labeling.
-
- Terminated Z-1926-2016
Loss of therapy during recharging of device. Reportedly, a charging session was terminated prior to obtaining recharge threshold voltage of 3.615, which triggered rapid battery depletion state. As a result, the device depleted to 1.925 volts in one to two days rather than the typical 30 days. Insufficient coupling between recharger and device during recharge session was found to be key factor.
-
- Terminated Z-1147-2015
Current labeling indicates that cycling improves device longevity in every programming scenario. However, enabling cycling at certain parameter settings may decrease the device battery longevity. With cycling enabled, longevity estimate displayed on the Model 8840Programmer may be inaccurate.
-
- Terminated Z-1524-2014
Medtronic neurostimulators (used with pain and deep brain stimulation therapy) have a cycling feature that, when enabled, allows stimulation output to be toggled on and off based on the programmed settings. The use of this feature is determined by the physician and set using the clinician programmer. Current labeling indicates the use of cycling improves device longevity and recharge interval
-
- Terminated Z-0278-2014
Medtronic notified customers regarding Loss of Stimulation of specific Implantable Neuro-Stimulators under the following specific conditions: Switching between groups with Multiple programs or creating program groups. Therapy can be restored with the Physician Recharge mode (RPM) of the Implantable Neurostimulator Recharger (INSR).
-
- Terminated Z-1536-06
Model 3777 Standard Octad Lead (Lot V009545) and Model 3778 Compact Octad Lead (Lot V009546) were mispackaged. The result of this error is that lead kits labeled 3777 lot V009545 may contain a 3778 compact-spaced lead, while those labeled 3778 lot V009546 may contain a 3777 standard-spaced lead. The result of this error is an overall increase or decrease of 14 mm in the electrode coverage.
Timeline
- Recall initiated FDA recalls Z-1147-2015
- Recall initiated FDA recalls Z-1926-2016
- Recall initiated FDA recalls Z-2159-2021
- Recall initiated FDA recalls Z-0780-2024
- Recall initiated FDA recalls Z-1691-2024
- Listed FDA GUDID 00763000371463
- Recall initiated FDA recalls Z-0372-2025
- Certificate issued EUDAMED G70 039709 1443
- Registered EUDAMED 0763000B00008798V
- Certificate expires EUDAMED G70 039709 1443
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Generic name
- Multiple active implantable device programmer
- Device name
- Stimulation RC Clinician Programmer App
- Model / reference
- A71400
- Primary DI / UDI-DI
- 00763000371463
- Basic UDI-DI
- 0763000B00008798V
- PMA number
- FDA product code
- LGW, QRB
- EMDN code
- J020782 Neurostimulators programmers - software accessories
- GMDN term
- Multiple active implantable device programmer
- Device class
- Class III
- Special device type
- Software
- EU registration type
- Standard device
- EU market of registration
- Netherlands
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under NEUROSTIMULATORS PROGRAMMERS AND ACCESSORIES.
- Barostim™ Programmer System 100067-201 by Cvrx, Inc.
- NCP® Programming Wand Model 201 by LivaNova USA, Inc.
- VNS Therapy® Model 250 v11.0 Programming Software by LivaNova USA, Inc.
- Evoke® Firmware Upgrade Application 1046 by Saluda Medical Pty Ltd
- Training Software For Visual Function Therapy SJ-MRS2016 by Guangzhou Shijing Medical Software Co., Ltd.
- Freelink™ SC-5240 by Boston Scientific Neuromodulation
- Evoke® RECAP® Viewer 1045 by Saluda Medical Pty Ltd